首页> 外文期刊>Vaccines >Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
【24h】

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform

机译:细胞膜涂层纳米颗粒作为新兴的抗菌疫苗平台

获取原文
           

摘要

Nanoparticles have demonstrated unique advantages in enhancing immunotherapy potency and have drawn increasing interest in developing safe and effective vaccine formulations. Recent technological advancement has led to the discovery and development of cell membrane-coated nanoparticles, which combine the rich functionalities of cellular membranes and the engineering flexibility of synthetic nanomaterials. This new class of biomimetic nanoparticles has inspired novel vaccine design strategies with strong potential for modulating antibacterial immunity. This article will review recent progress on using cell membrane-coated nanoparticles for antibacterial vaccination. Specifically, two major development strategies will be discussed, namely (i) vaccination against virulence factors through bacterial toxin sequestration; and (ii) vaccination against pathogens through mimicking bacterial antigen presentation.
机译:纳米颗粒已显示出增强免疫疗法效力的独特优势,并且对开发安全有效的疫苗制剂越来越感兴趣。最近的技术进步导致发现和开发了细胞膜包被的纳米颗粒,该颗粒结合了细胞膜的丰富功能和合成纳米材料的工程灵活性。这类新型的仿生纳米颗粒启发了新颖的疫苗设计策略,这些策略具有调节抗菌免疫的强大潜力。本文将回顾使用细胞膜包被的纳米颗粒进行抗菌接种的最新进展。具体而言,将讨论两个主要的发展策略,即(i)通过细菌毒素隔离接种针对毒力因子的疫苗; (ii)通过模仿细菌抗原呈递针对病原体的疫苗接种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号